Genesis BioNewsRound Award 2022

About the Award

The rationale behind this Award is to recognise and celebrate successes reported in the the past year.

In keeping with the life science innovation focus of Genesis, we are looking for entries that have demonstrated success in advancing their programme along the innovation pipeline, be that a new therapeutic, diagnostic or enabling technology.

Submitting your entry as a published press release, announcement or publication from the stated period also recognises that those that communicate their success will have a greater impact in building investor and policymaker confidence in the sector.

Therefore, the judges will select finalists based on three main criteria:

• The impact of the announced subject matter on the organisation’s development
• The significance to the Life Sciences sector as a whole
• The potential benefit to patients

Further details will be announced shortly